Share
Call them changemakers. Call them rule breakers. We call them Redefiners. And in this provocative podcast, we explore how daring leaders from across industries and around the globe are redefining their organizations—and themselves—to create extraordinary impact in today’s rapidly changing world. In each episode, Russell Reynolds Associates Leadership Advisor Hoda Tahoun and former CEO Clarke Murphy host engaging, purposeful conversations with leaders in and out of the business world who shar ...
…
continue reading
Manage episode 521045424 series 2426664
Content provided by Jobson Healthcare. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jobson Healthcare or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
This editorially independent content is sponsored by Astellas.
Carolyn Majcher, OD, FAAO, FORS, Director, Residency Programs and a professor at Oklahoma College of Optometry, notes how the conversation about geographic atrophy has changed with the introduction of complement inhibitor therapies. As most primary care optometrists have access to OCT technology, the opportunity to detect and potentially start treatments creates the opportunity to preserve vision for more patients.
This editorially independent content is sponsored by Astellas.
162 episodes
))
